Penny Stock Insider Trading
Tracking Executive Conviction in Stocks Under $5
Insider Activity in Low-Priced Equities
Insider trading in penny stocks often carries significant weight due to the high volatility inherent in smaller companies. When a director or CEO of a low-cap firm purchases shares, it can signal a major belief in an upcoming fundamental shift.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-28 18:01 | 2026-01-27 | VANI | Vivani Medical, Inc. | Williams Gregg | Director, 10% owner | Electromedical & Electrotherapeutic Apparatus | BUY | $1.48 | 1,351,351 | $1,999,999 | 27,915,460 | +5.1% |
| 2026-01-28 19:21 | 2026-01-27 | RCG | RENN Fund, Inc. | STAHL MURRAY | Officer, 10% owner - President/Co-Portfolio Manager | Other | BUY | $2.70 | 1,134 | $3,062 | 64,662 | +1.8% |
| 2026-01-29 04:02 | 2026-01-26 | USIO | Usio, Inc. | National Services, Inc | 10% owner | Functions Related To Depository Banking, NEC | SELL | $1.35 | 10,424 | -$14,104 | 2,749,616 | -0.4% |
| 2026-01-28 21:13 | 2026-01-28 | IRIX | IRIDEX CORP | Dizon Romeo R | Officer - Chief Financial Officer | Electromedical & Electrotherapeutic Apparatus | BUY | $1.46 | 1,300 | $1,898 | 111,589 | +1.2% |
| 2026-01-27 14:13 | 2026-01-23 | TOFB | TOFUTTI BRANDS INC | A-6684 Ltd. | 10% owner | Ice Cream & Frozen Desserts | BUY | $0.76 | 4,525 | $3,439 | 697,100 | +0.7% |
| 2026-01-28 04:19 | 2025-01-26 | MDBH | MDB Capital Holdings, LLC | James Jeremy William | Officer - CFO | Finance Services | SELL | $3.32 | 3,500 | -$11,621 | 19,839 | -15.0% |
| 2026-01-28 00:05 | 2026-01-23 | TSHA | Taysha Gene Therapies, Inc. | Alam Kamran | Officer - CHIEF FINANCIAL OFFICER | Biological Products, (No Diagnostic Substances) | SELL | $4.72 | 102,817 | -$485,039 | 1,443,786 | -6.6% |
| 2026-01-28 00:05 | 2026-01-23 | TSHA | Taysha Gene Therapies, Inc. | Nagendran Sukumar | Director, Officer - President and Head of R&D | Biological Products, (No Diagnostic Substances) | SELL | $4.72 | 116,050 | -$547,466 | 1,317,389 | -8.1% |
| 2026-01-28 00:05 | 2026-01-23 | TSHA | Taysha Gene Therapies, Inc. | Nolan Sean P. | Director, Officer - Chief Executive Officer | Biological Products, (No Diagnostic Substances) | SELL | $4.72 | 178,101 | -$840,191 | 2,908,257 | -5.8% |
| 2026-01-27 22:07 | 2026-01-27 | STEX | Streamex Corp. | Lekstrom Morgan Lee | Director, 10% owner | Electromedical & Electrotherapeutic Apparatus | BUY | $3.12 | 5,500 | $17,160 | 76,500 | +7.7% |
| 2026-01-27 20:58 | 2026-01-26 | STEX | Streamex Corp. | Lekstrom Morgan Lee | Director, 10% owner | Electromedical & Electrotherapeutic Apparatus | BUY | $3.30 | 23,000 | $75,900 | 71,000 | +47.9% |
| 2026-01-28 01:12 | 2026-01-27 | SERA | SERA PROGNOSTICS, INC. | Harrison Robert Gardner | Officer - Chief Information Officer | Services-Medical Laboratories | SELL | $2.97 | 2,000 | -$5,940 | 82,788 | -2.4% |
| 2026-01-28 00:47 | 2026-01-26 | DLPN | Dolphin Entertainment, Inc. | O'Dowd William IV | Director, Officer - Chief Executive Officer | Services-Personal Services | BUY | $1.81 | 2,700 | $4,874 | 428,790 | +0.6% |
| 2026-01-28 00:59 | 2026-01-23 | STEX | Streamex Corp. | GIUSTRA FRANK | 10% owner | Electromedical & Electrotherapeutic Apparatus | BUY | $3.00 | 1,000,000 | $3,000,000 | 1,178,205 | +561.2% |
| 2026-01-27 20:14 | 2026-01-26 | RCG | RENN Fund, Inc. | STAHL MURRAY | Officer, 10% owner - President/Co-Portfolio Manager | Other | BUY | $2.70 | 1,134 | $3,062 | 64,580 | +1.8% |
| 2026-01-28 02:23 | 2026-01-27 | THM | INTERNATIONAL TOWER HILL MINES LTD | PAULSON & CO. INC. | 10% owner | Metal Mining | BUY | $2.22 | 18,018,018 | $40,000,000 | 88,257,406 | +25.7% |
| 2026-01-27 21:14 | 2026-01-27 | IRIX | IRIDEX CORP | Dizon Romeo R | Officer - Chief Financial Officer | Electromedical & Electrotherapeutic Apparatus | BUY | $1.48 | 3,385 | $5,009 | 110,289 | +3.2% |
| 2026-01-27 01:38 | 2026-01-26 | ARCI | Archimedes Tech SPAC Partners III Co. | Archimedes Tech SPAC Sponsors III LLC | 10% owner | Blank Checks | BUY | $0.00 | 390,000 | $0 | 390,000 | +100.0% |
| 2026-01-27 01:38 | 2026-01-26 | ARCI | Archimedes Tech SPAC Partners III Co. | Long Long | Director, Officer, 10% owner - Chief Executive Officer | Blank Checks | BUY | $0.00 | 390,000 | $0 | 390,000 | +100.0% |
| 2026-01-26 21:10 | 2026-01-23 | STEX | Streamex Corp. | Williams Mitchell Young | Officer - Chief Investment Officer | Electromedical & Electrotherapeutic Apparatus | BUY | $3.03 | 51,511 | $155,852 | 1,051,511 | +5.2% |
| 2026-01-26 21:09 | 2026-01-23 | STEX | Streamex Corp. | Lekstrom Morgan Lee | Director | Electromedical & Electrotherapeutic Apparatus | BUY | $3.13 | 41,000 | $128,486 | 48,000 | +585.7% |
| 2026-01-26 19:48 | - | COSM | Cosmos Health Inc. | Siokas Grigorios | Director, Officer, 10% owner - Chief Executive Officer | Wholesale-Drugs, Proprietaries & Druggists' Sundries | BUY | $0.50 | 90,325 | $45,000 | 8,182,120 | +1.1% |
| 2026-01-27 03:22 | 2026-01-26 | MIGI | Mawson Infrastructure Group Inc. | Endeavor Blockchain, LLC | 10% owner | Finance Services | BUY | $4.84 | 60,000 | $290,400 | 1,460,000 | +4.3% |
| 2026-01-26 20:29 | 2026-01-23 | RCG | RENN Fund, Inc. | STAHL MURRAY | Officer, 10% owner - President/Co-Portfolio Manager | Other | BUY | $2.70 | 1,134 | $3,062 | 64,498 | +1.8% |
| 2026-01-27 01:17 | 2026-01-22 | USIO | Usio, Inc. | National Services, Inc | 10% owner | Functions Related To Depository Banking, NEC | SELL | $1.35 | 16,445 | -$22,275 | 2,760,040 | -0.6% |
| 2026-01-26 18:22 | 2026-01-26 | IRIX | IRIDEX CORP | Dizon Romeo R | Officer - Chief Financial Officer | Electromedical & Electrotherapeutic Apparatus | BUY | $1.52 | 1,243 | $1,889 | 106,904 | +1.2% |
| 2026-01-24 02:30 | 2026-01-22 | SES | SES AI Corp | Gan Hong | Officer - CHIEF SCIENCE OFFICER | Miscellaneous Electrical Machinery, Equipment & Supplies | OPT+S | $2.50 | 250,000 | -$624,700 | 1,253,286 | 0.0% |
| 2026-01-24 01:34 | 2026-01-23 | PLNH | Planet 13 Holdings Inc. | Wren Chris | Officer - VP of Operations | Agricultural Production-Crops | SELL | $0.19 | 30,000 | -$5,571 | 3,873,287 | -0.8% |
| 2026-01-24 00:45 | 2026-01-21 | AERG | Applied Energetics Inc. | Quarles Gregory James | Director, Officer - CEO Emeritus | Search, Detection, Navigation, Guidance, Aeronautical Sys | OPT+S | $1.87 | 6,600 | -$12,342 | 0 | 0.0% |
| 2026-01-24 00:15 | 2026-01-21 | ALLO | Allogene Therapeutics Inc. | Roberts Zachary | Officer - EVP of R&D | Biological Products, (No Diagnostic Substances) | SELL | $1.56 | 26,269 | -$40,980 | 616,866 | -4.1% |
| 2026-01-24 02:12 | 2026-01-21 | ABOS | Acumen Pharmaceuticals, Inc. | Meisner Derek M | Officer - Chief Legal Officer & Corp Sec | Biological Products, (No Diagnostic Substances) | SELL | $1.87 | 8,934 | -$16,721 | 173,999 | -4.9% |
| 2026-01-24 02:12 | 2026-01-21 | ABOS | Acumen Pharmaceuticals, Inc. | Siemers Eric | Officer - Chief Medical Officer | Biological Products, (No Diagnostic Substances) | SELL | $1.81 | 3,226 | -$5,833 | 255,371 | -1.2% |
| 2026-01-24 02:11 | 2026-01-21 | ABOS | Acumen Pharmaceuticals, Inc. | Zuga Matt | Officer - CFO & Chief Business Officer | Biological Products, (No Diagnostic Substances) | SELL | $1.83 | 4,160 | -$7,607 | 304,924 | -1.3% |
| 2026-01-24 02:10 | 2026-01-21 | ABOS | Acumen Pharmaceuticals, Inc. | OConnell Daniel Joseph | Director, Officer - Chief Executive Officer | Biological Products, (No Diagnostic Substances) | SELL | $1.83 | 12,035 | -$21,993 | 881,275 | -1.3% |
| 2026-01-24 02:10 | 2026-01-21 | ABOS | Acumen Pharmaceuticals, Inc. | Barton Russell | Officer - Chief Operating Officer | Biological Products, (No Diagnostic Substances) | SELL | $1.81 | 2,777 | -$5,031 | 205,092 | -1.3% |
| 2026-01-23 20:35 | 2026-01-22 | SER | Serina Therapeutics, Inc. | Moreadith Randall | Officer - Chief Scientific Officer | Pharmaceutical Preparations | OPT+S | $2.95 | 2,500 | -$7,375 | 0 | 0.0% |
| 2026-01-23 20:37 | 2026-01-22 | RCG | RENN Fund, Inc. | STAHL MURRAY | Officer, 10% owner - President/Co-Portfolio Manager | Other | BUY | $2.70 | 1,134 | $3,062 | 64,416 | +1.8% |
| 2026-01-23 22:48 | 2026-01-23 | IRIX | IRIDEX CORP | Dizon Romeo R | Officer - Chief Financial Officer | Electromedical & Electrotherapeutic Apparatus | BUY | $1.48 | 5,221 | $7,716 | 105,661 | +5.2% |
| 2026-01-22 19:29 | 2026-01-21 | LUCY | Innovative Eyewear Inc | Gross Harrison R. | Director, Officer - Chief Executive Officer | Ophthalmic Goods | BUY | $1.32 | 1,500 | $1,980 | 13,733 | +12.3% |
| 2026-01-23 05:46 | 2026-01-20 | PLRX | PLIANT THERAPEUTICS, INC. | Cummings Keith Lamont | Officer - Chief Financial Officer | Pharmaceutical Preparations | SELL | $1.28 | 24,002 | -$30,723 | 297,214 | -7.5% |
| 2026-01-23 05:38 | 2026-01-20 | PLRX | PLIANT THERAPEUTICS, INC. | Cheung Lily | Officer - Chief Human Resource Officer | Pharmaceutical Preparations | SELL | $1.28 | 7,534 | -$9,644 | 44,847 | -14.4% |
| 2026-01-23 05:38 | 2026-01-20 | PLRX | PLIANT THERAPEUTICS, INC. | Coulie Bernard | Director, Officer - President and CEO | Pharmaceutical Preparations | SELL | $1.28 | 89,375 | -$114,400 | 505,601 | -15.0% |
| 2026-01-23 05:38 | 2026-01-20 | PLRX | PLIANT THERAPEUTICS, INC. | Kuo Minnie | Officer - Chief Operating Officer | Pharmaceutical Preparations | SELL | $1.28 | 6,917 | -$8,854 | 37,806 | -15.5% |
| 2026-01-23 01:47 | 2026-01-20 | CSAI | CLOUDASTRUCTURE, INC. | Bentley Sheldon Richard | 10% owner, Other | Services-Computer Programming, Data Processing, Etc. | SELL | $0.84 | 50,000 | -$42,000 | 150,000 | -25.0% |
| 2026-01-23 00:10 | 2026-01-21 | YYAI | AIRWA INC. | Zhou Hongyu | Director | Services-Computer Programming, Data Processing, Etc. | BUY | $1.37 | 4,215,000 | $5,774,550 | 5,816,489 | +263.2% |
| 2026-01-23 05:55 | 2026-01-16 | RMCF | Rocky Mountain Chocolate Factory, Inc. | GEYGAN JEFFREY RICHART | Director, Officer, 10% owner - Interim CEO | Sugar & Confectionery Products | BUY | $1.98 | 11,300 | $22,353 | 1,792,478 | +0.6% |
| 2026-01-23 03:34 | 2026-01-20 | RXRX | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher | Director | Biological Products, (No Diagnostic Substances) | SELL | $4.47 | 40,000 | -$178,800 | 913,839 | -4.2% |
| 2026-01-23 00:16 | 2026-01-20 | MNTR | Mentor Capital, Inc. | Billingsley Chester | Director, Officer, 10% owner - Chief Executive Officer | Investors, NEC | BUY | $0.09 | 3,800 | $336 | 3,165,296 | +0.1% |
| 2026-01-22 15:00 | 2026-01-21 | RNXT | RenovoRx, Inc. | Agah Ramtin | Director, Officer - Chief Medical Officer | Pharmaceutical Preparations | BUY | $1.00 | 10,000 | $9,975 | 798,460 | +1.3% |
| 2026-01-23 05:55 | 2026-01-16 | RMCF | Rocky Mountain Chocolate Factory, Inc. | GLOBAL VALUE INVESTMENT CORP. | 10% owner | Sugar & Confectionery Products | BUY | $1.98 | 11,300 | $22,353 | 1,971,306 | +0.6% |
High Risk, High Reward Insider Trades
Penny stocks are notoriously volatile, but when insiders put their own money into stocks priced under $5, it provides a unique layer of validation. Unlike large-cap stocks where buys might be routine, a million-share purchase at $0.50 can indicate that management sees a path to recovery or exponential growth. Our tracking allows you to identify ini speculative signals in real-time, focusing on the capital flow of those with intimate industry knowledge. Following these low-cap moves helps bridge the information gap in the most volatile market segments.
Identifying Legitimate Micro-Cap Conviction
Our Penny Stock Filter isolates the most speculative yet promising filings from the SEC Form 4 feed. By focusing on low-priced equities, we highlight where CEOs and Directors are taking meaningful positions. This list is essential for small-cap investors looking to follow the capital of those with intimate knowledge of a company's research, patents, or upcoming regulatory approvals. Eliminate the noise and focus strictly on high-impact accumulation from leadership betting big on their company’s future value in the micro-cap space.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.